A

Stabilizing the Closed SARS-CoV-2 Spike Trimer

bioRxiv (Cold Spring Harbor Laboratory)

Abstract

Abstract The trimeric spike (S) protein of SARS-CoV-2 is the primary focus of most vaccine design and development efforts. Due to intrinsic instability typical of class I fusion proteins, S tends to prematurely refold to the post-fusion conformation, compromising immunogenic properties and prefusion trimer yields. To support ongoing vaccine development efforts, we report the structure-based design of soluble S trimers, with increased yields and stabilities, based on introduction of single point mutations and disulfide-bridges. We identify two regions in the S-protein critical for the protein’s stability: the heptad repeat region 1 of the S2 subunit and subunit domain 1 at the interface with S2. We combined a minimal selection of mostly interprotomeric mutations to create a stable S-closed variant with a 6.4-fold higher expression than the parental construct while no longer containing a heterologous trimerization domain. The cryo-EM structure reveals a correctly folded, predominantly closed pre-fusion conformation. Highly stable and well producing S protein and the increased understanding of S protein structure will support vaccine development and serological diagnostics.

Authors 9

  1. Janssen (Netherlands)

    Affiliation as printed

    Janssen Vaccines & Prevention BV, Leiden, the Netherlands

  2. Janssen (Netherlands)

    Affiliation as printed

    Janssen Vaccines & Prevention BV, Leiden, the Netherlands

  3. Janssen (Netherlands)

    Affiliation as printed

    Janssen Vaccines & Prevention BV, Leiden, the Netherlands

  4. Janssen (Netherlands)

    Affiliation as printed

    Janssen Vaccines & Prevention BV, Leiden, the Netherlands

  5. Janssen (Netherlands)

    Affiliation as printed

    Janssen Vaccines & Prevention BV, Leiden, the Netherlands

  6. Janssen (Netherlands)

    Affiliation as printed

    Janssen Vaccines & Prevention BV, Leiden, the Netherlands

  7. Janssen (Netherlands)

    Affiliation as printed

    Janssen Vaccines & Prevention BV, Leiden, the Netherlands

  8. Leiden University

    Affiliation as printed

    NeCEN, Leiden University, Einsteinweg 55, Leiden, the Netherlands

  9. Janssen (Netherlands)

    Affiliation as printed

    Janssen Vaccines & Prevention BV, Leiden, the Netherlands

Cited by 8 stored of 12

8 results

No patents citing this paper on Lens.org (checked 2026-10-11).

References 48